Condition · Musculoskeletal & Injury

Wound Healing / Tissue Repair

Background biology

Healing involves inflammation, angiogenesis, cell migration, extracellular matrix deposition and remodelling.

Evidence-ranked peptides

Peptide	Use	Evidence
GHK-Cu GHK-Cu is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human2/5 Animal2/5 Safety2/5 3 verified refs
Thymosin Beta 4 Thymosin Beta 4 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human1/5 Animal3/5 Safety0/5 3 verified refs
BPC-157 BPC-157 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human1/5 Animal0/5 Safety0/5 2 verified refs
B7-33 An experimental biased RXFP1 agonist developed to reproduce selected vasodilatory and antifibrotic actions of relaxin.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal2/5 Safety0/5 1 verified ref
LL-37 LL-37 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
TB-500 TB-500 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
Relaxin 2 Relaxin 2 is an endogenous signalling peptide with established or emerging physiological relevance.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
Pegylated Bpc Analogue Pegylated Bpc Analogue is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
RGDS Peptide RGDS Peptide is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
Copper Tripeptide-1 Copper Tripeptide-1 is used or marketed in topical cosmetic formulations, with peptide-specific clinical evidence that is limited or formulation-dependent.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
RGD Peptide RGD Peptide is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs
Thymosin Beta 10 Thymosin Beta 10 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.	Wound Healing / Tissue Repair insufficient	Human0/5 Animal0/5 Safety0/5 0 verified refs

Current standard management

conventional medicine

Appropriate wound care, infection control, pressure reduction and specialist care remain central.

Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.

Linked mechanisms

biological pathways discussed for this condition

Wound repairneeds review
Angiogenesisneeds review
Collagen synthesisneeds review
Fibroblast activationneeds review
Antimicrobial activityneeds review
Angiogenesislimited
Wound repairlimited
Inflammation modulationlimited
Collagen synthesislimited
Antimicrobial activitylimited
Immune modulationlimited
Relaxin family peptide receptor signallinglimited
Nitric oxide / blood flowlimited
Actin cytoskeleton and cell migrationlimited

Research gaps

what we don't know yet

·Clinical evidence is indication-specific
·Animal findings may not translate
·Product identity and formulation vary

Community observations

No approved community reports for this condition yet. Submit one.

Clinician discussion

Questions you can ask a qualified clinician

What are the established evidence-based options for this condition?
What monitoring is appropriate before considering any experimental intervention?
What long-term safety data exists for peptide-based approaches?
Are there licensed medicines relevant to my situation?

↳

Explore further

from the knowledge graph

Peptides that touch this

Mechanisms in play

Advertise here — support independent evidence →